MNTA

Momenta Pharmaceuticals, Inc.
MNTA

Overview Fund Activity
Delisted

MNTA was delisted on the 30th of September, 2020.

Back to rankings

156 hedge funds and large institutions have $1.02B invested in Momenta Pharmaceuticals, Inc. in 2015 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 66 increasing their positions, 44 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
156
Holders Change
-6
Holders Change %
-3.7%
% of All Funds
4.36%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
21
Increased
66
Reduced
44
Closed
26
Calls
$5.78M
Puts
$3.37M
Net Calls
+$2.41M
Net Calls Change
+$1.09M

Top Buyers

1
VAM
1
Visium Asset Management
New York
$88.6M
2
Citadel Advisors
2
Citadel Advisors
Florida
$14.1M
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$169M
4
DCM
4
Discovery Capital Management
Connecticut
$75.5M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$77.3M

Top Sellers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$21.7M
2
BIM
2
Bogle Investment Management
Massachusetts
$450K
3
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$4.1M
4
DCM
4
Driehaus Capital Management
Illinois
$0
5
CCMU
5
Cheyne Capital Management (UK)
United Kingdom
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
TRCT
176
Tower Research Capital (TRC)
New York
– -$116K -5,070 Closed
Simplex Trading
177
Simplex Trading
Illinois
– -$26K -1,172 Closed
PAM
178
Panagora Asset Management
Massachusetts
– -$20K -879 Closed
Bessemer Group
179
Bessemer Group
New Jersey
– -$3K -121 Closed
TCM
180
Tradewinds Capital Management
Washington
– -$2K -100 Closed
FANJ
181
Financial Architects (New Jersey)
New Jersey
– -$2K -70 Closed
4 5 6 7
8